SUBSCRIBE

Breaking News on Biopharmaceutical Development & Manufacturing

Headlines > Downstream Processing

Gone to the dogs? Shire sells vaccine plant to Merck Animal Health

23-Aug-2017 - Shire has sold the former Baxalta vaccine facility in Austria to Merck Animal Health for an undisclosed fee.

Bioproduction bottlenecks increasing due to staff shortages, says report

16-Aug-2017 - A shortage in expertise is causing bottlenecks in the biomanufacturing space with around half of drugmakers struggling to fill processing positions, an industry report finds.

Trellis selects CMC Biologics to make mAb therapies

08-Aug-2017 - CMC Biologics and Trellis Bioscience are teaming up to make monoclonal antibody (mAb)-based therapies.

Celltrion Healthcare $890m IPO to up biosimilar inventory and broaden portfolio

04-Aug-2017 - Celltrion Healthcare will purchase more biosimilars from biomanufacturing partner Celltrion Inc. and expand its distribution network after raising one trillion Won ($888m) in an IPO.

Repligen closes Spectrum acquisition in latest boost for filtration business

04-Aug-2017 - Filtration drove a record quarter for Repligen which says the addition of Spectrum Pharmaceuticals will further grow its bioprocessing portfolio and geographical presence.

Thermo Fisher: Modest Q2 for life sciences due to ‘lumpiness’ of bioproduction

01-Aug-2017 - Muted bioproduction technology pegged back an otherwise strong quarter, but Thermo Fisher says it expects growth will pick up again over time.

Lonza sets CHF7.5bn 2022 sales target citing pharma drivers

26-Jul-2017 - Lonza Group AG has predicted it will generate annual revenue of CHF7.5bn ($7.9bn) by 2022, citing recent acquisition Capsugel and its new Visp-based Ibex manufacturing service as drivers.

Mylan's EU biosimilar ambition hit by GMP issues at Biocon plant

10-Jul-2017 - Three biosimilar products submitted to the EU for approval have suffered a setback after regulators found 35 GMP deficiencies at Biocon’s fill/finish facility in Bangalore, India.

EC says Merck and Sigma-Aldrich broke M&A procedures and could face $170m fine

06-Jul-2017 - German Merck and Sigma-Aldrich broke EU merger procedures and could face a fine equivalent to 1% of the combined firm's annual revenue according to the European Commission

Pump up the volume: Cellnovo adding insulin device line in Romania

04-Jul-2017 - French technology firm Cellnovo has selected Flex Ltd to build a production line in Romania, to manufacture insulin cartridges for its diabetes management system.

Patheon to spend $45m on manufacturing plants ahead of Thermo takeover

30-Jun-2017 - Patheon NV has announced it will spend $45m to expand and enhance its manufacturing network citing customer demand for more reliable, flexible and cost-efficient supply chains.

Repligen CEO says Spectrum acquisition fills gap in bioprocessing product line

27-Jun-2017 - Repligen Corporation has announced it will acquire filtration-focused Spectrum Pharmaceuticals for approximately $350m (€312m).

Protein A resin maker teams on continuous and column-free chromatography tech

23-Jun-2017 - ChromaTan will incorporate Purolite’s Protein A beads into its continuous platform in a move the firms say will up productivity by 15 times over conventional batch chromatography.

Sanofi outlines €600m biologics manufacturing investment plan

16-Jun-2017 - Sanofi has said it will spend €600m ($673m) to increase capacity to make biologic drugs over the next three years.

Keeping it in the family: Rentschler to offer fill and finish services

13-Jun-2017 - Rentschler Biotechnologie has entered into a strategic partnership with Rentschler Fill Solutions to offer its clients aseptic fill and finish services.

Update - BioMarin to hire 50 people at Shanbally

US FDA clears BioMarin to make $380,000-a year Vimizim in Ireland

12-Jun-2017 - The US FDA has cleared BioMarin Pharmaceutical Inc. to make the enzyme replacement drug Vimizim (elosulfase alfa) at its plant in Cork, Ireland.

Takeda breaks ground on $45m Ninlaro plant in Ireland

06-Jun-2017 - Takeda has begun construction of an Irish facility to support production of its orally delivered blood cancer peptide Ninlaro (ixazomib).

LSNE tapped for drug substance manufacturing, fill/finish services

25-May-2017 - LSNE Contract Manufacturing has signed a manufacturing supply agreement with Selecta Biosciences, Inc. through which the CDMO will advance Selecta’s lead candidate, SEL-212.

Amgen: Bioprocess intensification and integration key for next-generation manufacturing

23-May-2017 - Its new Singapore single-use plant is a fraction of the size of a conventional commercial facility but next-generation biomanufacturing at Amgen points to even smaller, more integrated sites.

Industry 4.0 making its mark in biomanufacturing sector, Thermo Fisher

10-May-2017 - Integrating single-use, automation and continuous processing equipment will be the future for bioproduction says Thermo Fisher acquisition Finesse Solution.

BPI EUROPE 2017

Continuous chromatography and single-use filtration at BPI Europe

03-May-2017 - Pall Corporation, GE Healthcare and LEWA Process Technologies showed off their latest downstream offerings to Biopharma-Reporter in Amsterdam last week.

GSK to ship malaria vaccine for African pilot programme

28-Apr-2017 - GSK says maintaining an unbroken cold chain will be critical as it prepares to rollout malaria vaccine pilot programme. 

Filtration is a ‘high value process at a marginal cost,’ says Danaher

25-Apr-2017 - Danaher reported mid-single-digit growth from its bioprocessing subsidiary Pall Life Science and expects a continued trajectory to support Biopharma’s filtration needs.

MilliporeSigma launches M-pleat pattern single-use filters

14-Apr-2017 - MilliporeSigma has launched a range of high area cartridges and single use capsules it says gives biomanufacturers greater efficiency in the filtration step.

GE aiming to be cell therapy production services one-stop-shop

12-Apr-2017 - GE Healthcare has acquired cryopreservation technology firm Asymptote and says more investments are likely as it builds an “end-to-end ecosystem” for cellular therapy production services.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...